Intellia Therapeutics (NTLA) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.39
-1.25
-1.12
-0.98

Details

Expected EPS
-1.017696
Actual EPS
-0.98
Surprise EPS
0.04
Surprise Percent
+3.7%

Description

Intellia Therapeutics (NTLA) has reported earnings of -0.98 per share for Q3 2025.

0 Comments

Share your thoughts